|Image 1: If that were a peace of meat, I'd |
say its roadkill, in the case of these
Ecklonia cava algae the term "floatsam"
would probably be more fitting,
though (photo by Nikemoto2511)
For 12 weeks, a group of 97 overweight (not obese; BMI 24-29kg/m²) Koreans (mean age 40.5yr) consumed a test liquid containing 0 g of fructose, 0.65 g of dextrin, 12mg of sucralose, 0.15 g of sodium chloride, 0.6 g of citric acid, 0.15 g of vitamin C and lemon ﬂavor. Depending on which group (C, LD, HD) the respective subject had been assigned to, the content of the otherwise identical cans held had been enriched by 0mg (C), 72mg (LD) or 142mg (HD) of an Ecklonia cava extract with a total polyphenol content of 98.5% (measured in phloroglucinol equivalents). The subjects were adviced to consume the drink in between meals, but otherwise to maintain "their usual dietary intake and physical activity", so that any changes in antropometric measurements, dietary intakes and biochemical and hematologic parameters would be attributable to the Ecklonia cava polyphenol (ECP) supplementation.
|Figure 1: Anthropometric changes in 97 overweight Koreans after 12 weeks of 0mg=control, 72mg=ECP(72) and 144mg=ECP(144) supplemtal Ecklonia cava polyphenols (data calculated based on Shin. 2011)|
- In contrast to some other natural weight loss supplements (cf. yesterday's news on green tea extract), the dose response curve does not seem to flatten out. At least within the range that has been tested in this study, doubling the dosage even produced a 2.25-fold increase in body fat loss.
- The polyphenol extract does not seem to work its magic by appetite suppression. As the data in figure 1 shows, the difference between calorie intake and estimated calorie expenditure did even rise by 4.7% and 5.5% in the ECP(72) and the ECP(144) group respectively (judged by the estimated calorie-expenditures both groups had a minimal caloric surplus of 79 and 106kcal).
As far as the mechanism of action, responsible for the highly appreciable effects on body composition, blood lipids and, at high doses, glucose management (-4.9% blood glucose in the ECP(144) group) are concerned the scientists are yet still in the dark:
The antidyslipidemic mechanism of the phlorotannins is not clear. Based on the moderate inhibition of cholesterol esterase (IC50 = ~100 μg/mL on porcine pancreatic cholesterol esterase, unpublished result) by ECP, inhibition of cholesterol absorption may partly contribute to this effect. Other mechanistic speculations include protection of liver function from chronic exposure to high‐fat or high‐glycemic diet. [...] In the present study, significant reduction was observed of serum ALT and AST levels in ECP‐supplemented groups compared with the placebo group. Therefore, based on its antioxidant, antiinflammatory, and hepatoprotective (Kim et al., 2005) activities, ECP might possibly contribute to normalization of blood lipids byBe that as is may, as long as it entails small, but statistically significant, side-effect-free improvements in body-composition, lipid profile and glucose management, I doubt any overweight end-consumer will give a damn about the underlying molecular mechanisms which certainly won't make the necessary lifestyle changes obsolete, but could potentially multiply and accelerate their effects.
suppressing fat‐induced damage of liver tissue.